The 10th cohort of MassChallenge accelerator program in Boston pitted 125 hopeful startups against each other for a chance to win a cash prize with zero equity. Legacy struck gold winning in the healthcare and life sciences category, and took home $50K in cash. Legacy triumphed over the competition with its innovative concept of disrupting men’s fertility, but ultimately won over the judges with the company’s brand as a fatherhood planning resource.
The company’s competitive advantage was not only centered around its ability to address an underserved niche, but also Legacy’s ability to bring male fertility to the forefront of the conversation around men’s health. Legacy founder and CEO, Khaled Kteily, remains steadfast in the companies social mission of creating an equitable future when it comes to family planning. “We at Legacy believe that sperm testing should be a routine part of men’s health,” said Kteily. The award recognition and the funds will help further Legacy’s continued growth and expand the company services to healthcare providers. “The competition was qualified but, our company’s unique service and mission is unmatched,”said Kteily.
About MassChallenge: MassChallenge is a global network of zero-equity startup accelerators. Headquartered in the United States with locations in Boston, Israel, Mexico, Rhode Island, Switzerland, and Texas, MassChallenge is committed to strengthening the global innovation ecosystem by supporting high-potential startups across all industries, from anywhere in the world. To date, our 2,344 MassChallenge alumni have raised more than $5 billion in funding, generated more than $2.7 billion in revenue, and created more than 136,000 total jobs. Learn more about MassChallenge at masschallenge.org.